Full text loading...
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma
1.M. Sarfaraz, A. S. Kennedy, Z. J. Cao, G. D. Sackett, C. X. Yu, M. A. Lodge, R. Murthy, B. R. Line, and D. A. Van Echo, “Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors,” Med. Phys. 30, 199–203 (2003).
2.J. Dancey, F. A. Shepard, K. Paul, K. W. Sniderman, S. Houle, J. Gabrys, A. Hendler, and J. E. Goin, “Treatment of nonresectable hepatocellular carcinoma with intrahepatic Y-90 microspheres,” J. Nucl. Mater. 41, 1673–1681 (2000).
3.W. Lau, S. Ho, T. W. T. Leung, M. Chan, R. Ho, P. J. Johnson, and A. K. C. Li, “Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of yttrium-90 microspheres,” Int. J. Radiat. Oncol., Biol., Phys. 40, 583–592 (1998).
4.J. Andrews, S. C. Walker, R. J. Ackerman, L. A. Cotton, W. D. Ensminger, and B. Shapiro, “Hepatic radioembolization with yttrium-90 containing glass microspheres: Preliminary results and clinical follow-up,” J. Nucl. Mater. 35, 1637–1644 (1994).
5.B. Gray, J. E. Anderson, M. A. Burton, G. Van Hazel, J. Codde, C. Morgan, and P. Klemp, “Regression of liver metastases following treatment with yttrium-90 microspheres,” Aust. N. Z. J. Surg. 62, 105–110 (1992).
6.S. Ho, W. Y. Lau, T. W. Leung, M. Chan, Y. K. Ngar, P. J. Johnson, and A. K. Li, “Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumors,” Eur. J. Nucl. Med. 23, 947–952 (1996).
7.P. Roberson, R. K. Ten Haken, D. L. McShan, P. E. McKeever, and W. D. Ensminger, “Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy,” J. Nucl. Med. 33, 735–738 (1992).
8.A. Campbell, I. H. Bailey, and M. A. Burton, “Tumor dosimetry in human liver following hepatic yttrium-90 microsphere therapy,” Phys. Med. Biol. 46, 487–498 (2001).
9.R. Fox, P. F. B. Klemp, G. Egan, L. L. Mina, M. A. Burton, and B. N. Gray, “Dose distribution following selective internal radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 21, 463–467 (1991).
10.G. S. S. Sgouros, A. M. Ballangrud, K. S. Kolbert, J. B. Teitcher, K. S. Panageas, R. D. Finn, C. R. Divgi, S. M. Larson, and A. D. Zelenetz, “Patient-specific, 3-dimensional dosimetry in non-Hodgkin’s lymphoma patients treated with I131-anti-B1 antibody: Assessment of tumor dose-response,” J. Nucl. Med. 44, 260–268 (2003).
11.K. S. S. G. Kolbert, A. M. Scott, J. E. Bronstein, R. A. Malane, J. Zhang, H. Kalaigian, S. McNamara, L. Schwartz, and S. M. Larson, “Implementation and evaluation of patient-specific three-dimensional internal dosimetry,” J. Nucl. Med. 38, 301–308 (1997).
12.M. Sarfaraz, X. Wu, M. A. Lodge, and C. X. Yu, “Automatic CT-SPECT registration of livers treated with radioactive microspheres,” Phys. Med. Biol. 49, N131–N137 (2004).
13.A. Bielajew and D. W. O. Rogers, “The parameter reduced electron-step transport algorithm for electron Monte Carlo transport,” Nucl. Instrum. Methods Phys. Res. B 18, 165–181 (1987).
14.W. Nelson, H. Hirayama, and D. W. O. Rogers, “The EGS4 code system,” Stanford, CA, 1985.
15.D. Rogers and A. F. Bielajew, “Monte Carlo techniques of electron and photon transport for radiation dosimetry,” in The Dosimetry of Ionization Radiation, edited by B. E. B. K. R. Kase and F. H. Attix (Academic, New York, 1990), pp. 427–539.
16.C. Ma, P. Reckwerdt, M. Holmes, D. W. O. Rogers, and B. Geiser, DOSXYZ users manual, 1995, NRC.
17.W. Cross, H. Ing, and N. Freedman, “A short atlas of beta-ray spectra,” Phys. Med. Biol. 28, 1251–1260 (1983).
18.J. M. Franquiz, and C. S. Kandagatla, “Technical note: Beta voxel S values for internal emitter dosimetry,” Med. Phys. 30, 1030–1032 (2003).
19.W. E. Bolch et al., “MIRD Pamphlet No. 17: The dosimetry of nonuniform activity distributions-radionuclides S values at the voxel level,” J. Nucl. Mater. 40, 11S–36S (1999).
20.B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. E. Munzenrider, B. Shank, L. J. Solin, and M. Wesson, “Tolerance of normal tissue to therapeutic irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 21, 109–122 (1991).
21.L. Dawson, N. Daniel, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, “Analysis of radiation-induced liver disease using the Lyman NTCP model,” Int. J. Radiat. Oncol., Biol., Phys. 53, 810–821 (2002).
Article metrics loading...